VRd, sometimes called RVd, represents a specific drug combination used to treat multiple myeloma, a type of blood cancer. It is a chemotherapy regimen.
Understanding VRd in Multiple Myeloma Treatment
Multiple myeloma (MM) is a cancer that develops in plasma cells, a type of white blood cell. Cancerous myeloma cells can accumulate in the bones or bone marrow over time. VRd is a common treatment option for this condition.
VRd Drug Components
VRd is an acronym that stands for the following medications:
| Drug Name | Also Called |
|---|---|
| Velcade | Bortezomib |
| Revlimid | Lenalidomide |
| dexamethasone | A steroid |
This combination targets myeloma cells through different mechanisms, aiming to kill them or slow their growth.
